XML 63 R50.htm IDEA: XBRL DOCUMENT v3.23.3
Variable Interest Entities (Additional Information) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2022
Jun. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Mar. 31, 2023
Aggregate carrying value of assets $ 801,230       $ 801,230   $ 942,598
Aggregate Carrying Value of total liabilities 175,979       175,979   $ 228,659
Recognized revenue [1] 49,999   $ 75,659   110,863 $ 140,172  
Net loss attributable to common stockholders (75,270) $ (104,624) (66,065) $ (89,532) (179,894) (155,597)  
VIE [Member]              
Recognized revenue 8,500   10,400   17,500 21,100  
Net loss attributable to common stockholders $ 3,300   $ 1,700   $ 5,800 $ 2,100  
[1] There was no Therapeutics revenue for the three and six months ended September 30, 2023 and 2022.